Neogene Therapeutics�� Post

View organization page for Neogene Therapeutics, graphic

13,517 followers

Today, Neogene announced that it has entered into a definitive agreement to be acquired by AstraZeneca. This is an exciting opportunity to combine our expertise and capabilities and bring next-generation T cell therapies (TCR-Ts) to patients with solid cancers. Read more about this announcement here: https://lnkd.in/eNS6dyPB #oncology #celltherapy 

  • No alternative text description for this image
Nicola Redfern

Consult, coach, collaborate, connect - sharing insights & supporting multiple organisations in the gene therapy, oncology and rare disease world - open to discussions.

1y

If this helps ensure innovation gets to patients it has to be a good thing BUT a little part of me sinks when smaller organisations potentially disappear into bigger pharma. Hope it goes well for all concerned.

Cheryl Collett, CPA

Chief Financial Officer at Toragen, Inc.

1y

Congratulations Jin L. and all Neogene team members.

Anastasija Nufer

Solution-oriented, ambitioned, creative | MBA & MSc

1y

Congratulations on the partnership!

Vikram Gupta

Digital Health Leader Pharma/Life Science

1y

Congratulations Harish and team!!

Ashley H.

Chief Development Officer at Reneo Pharmaceuticals

1y

Congrats to the Neogene Team!

Julian Jude, PhD

Driving innovation in SynBio and genetic medicine - partnering with pioneers to shape the future | Functional Genomics Consultant | CRISPR Expert

1y

Congratulations! What exciting news.

Tiffany Sidwell, MB(ASCP)ᶜᵐSCYMᶜᵐ

Scientist, Flow Cytometry, Analytical Development

1y

Amazing!! Congrats Neogene friends!

Like
Reply
Jonathan Crider, Ph.D.

Microbiology and Immunology Ph.D. with a Flow Cytometry and Bioinformatics/Genomics Background, Commercial Experience, and a Passion for Communicating

1y

Wow! Congrats and very exciting science!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics